An unusual clinical manifestation of a relapsed typical pulmonary carcinoϊd tumor
- PMID: 34458087
- PMCID: PMC8378835
- DOI: 10.1016/j.rmcr.2021.101401
An unusual clinical manifestation of a relapsed typical pulmonary carcinoϊd tumor
Abstract
Typical carcinoid tumors of the lungs carry an excellent prognosis after complete surgical excision. However, recurrence of these cancers remains poorly described in the literature and may occur many years after surgery. We report a case of carcinoid tumor of the lung. Clinical presentation and follow-up were uneventful. The 55 years old patient had got a surgical removal of a huge typical carcinoid tumor of the left lung. A left pneumonectomy with a mediastinal lymph node resection were performed. Thirteen years later, paraneoplastic acromegaly revealed a pulmonary and extrapulmonary recurrence of the tumor. We prescribed a chemotherapy regimen including Cisplatin and Etoposide. Endocrine paraneoplastic syndromes are related to mutations in specifically known genes. Several mutations may become a promising therapeutic target in the future. In the case of neuro-endocrine pulmonary tumors, authors described BCOR gene mutation as an oncogenic development inducer and an eventual generator of ectopic tumoral secretions. The more we get familiar with carcinoid tumor mutations, the closer we get to targeted therapy for non-resectable tumors.
Keywords: Acromegaly; Carcinoid tumor; Paraneoplastic syndrome; Recurrence.
© 2021 The Author(s).
Conflict of interest statement
Interests related to the manuscript theme: None.
Figures



Similar articles
-
[The ectopic ACTH syndrome].Srp Arh Celok Lek. 2004 Jan-Feb;132(1-2):28-32. doi: 10.2298/sarh0402028p. Srp Arh Celok Lek. 2004. PMID: 15227962 Serbian.
-
Surgical management of bronchopulmonary typical carcinoid tumors: an institutional experience.Interact Cardiovasc Thorac Surg. 2010 Dec;11(6):737-9. doi: 10.1510/icvts.2010.247361. Epub 2010 Sep 19. Interact Cardiovasc Thorac Surg. 2010. PMID: 20852330
-
Pulmonary carcinoid tumors with Cushing's syndrome: an aggressive variant or not?Ann Thorac Surg. 2005 Apr;79(4):1132-6; discussion 1132-6. doi: 10.1016/j.athoracsur.2004.07.021. Ann Thorac Surg. 2005. PMID: 15797039
-
Late recurrent pulmonary typical carcinoid tumor: case report and review of the literature.Mt Sinai J Med. 2006 Oct;73(6):884-6. Mt Sinai J Med. 2006. PMID: 17117316 Review.
-
Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.Pituitary. 2006;9(3):221-9. doi: 10.1007/s11102-006-0267-0. Pituitary. 2006. PMID: 17036195 Review.
References
-
- Thomas C.F., Tazelaar H.D., Jett J.R. Typical and atypical pulmonary carcinoids: outcome in patients presenting with regional lymph node involvement. Chest. 2001;119(4):1143–1150. - PubMed
-
- Fjällskog M.-L.H., Janson E.T., Falkmer U.G., Vatn M.H., Öberg K.E., Eriksson B.K. Treatment with combined streptozotocin and liposomal doxorubicin in metastatic endocrine pancreatic tumors. Neuroendocrinology. 2008;88(1):53–58. https://www.karger.com/Article/FullText/117575 - PubMed
-
- García-Yuste M., Matilla J.M., Cueto A., Paniagua J.M.R., Ramos G., Cañizares M.A. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish multi-centric study of neuroendocrine tumours of the lung. Eur. J. Cardio. Thorac. Surg. Off. J. Eur. Assoc. Cardio-Thorac. Surg. 2007;31(2):192–197. - PubMed
-
- Moertel C.G., Johnson C.M., McKusick M.A., Martin J.K., Nagorney D.M., Kvols L.K. The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann. Intern. Med. 1994;120(4):302–309. - PubMed
Publication types
LinkOut - more resources
Full Text Sources